Insulin prophylaxis in individuals at high risk of type 1 diabetes

No abstract is available for this paper.

• Publication year

  1993

• Venue

  The Lancet

• Publication date

  1993-04-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0140-6736(93)91215-8
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulitis and Diabetes in NOD Mice Reduced by Prophylactic Insulin Therapy

  1990cited by this paper
• Predicting Type I Diabetes

  1990cited by this paper
• A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus.

  1989cited by this paper
• Interaction of β-Cell Activity and IL-1 Concentration and Exposure Time in Isolated Rat Islets of Langerhans

  1989cited by this paper
• Competitive Insulin Autoantibody Assay: Prospective Evaluation of Subjects at High Risk for Development of Type I Diabetes Mellitus

  1987cited by this paper

• Disrupted RNA editing in beta cells mimics early stage type 1 diabetes

  2022cites this paper
• 100 Years of Insulin: Lifesaver, immune target, and potential remedy for prevention.

  2021cites this paper
• The dark side of insulin: A primary autoantigen and instrument of self-destruction in type 1 diabetes

  2021cites this paper
• Prevention of Autoimmune Disease: The Type 1 Diabetes Paradigm

  2020cites this paper
• First phase insulin response in children with islet autoantibodies : results from the Finnish Type 1 Diabetes Prediction and Prevention study

  2019cites this paper
• Chapter 2 Latent Autoimmune Diabetes in Adults

  2019cites this paper
• Effect of screening for type 1 diabetes on early metabolic control: the DiPiS study

  2018cites this paper
• 66 – Technologies for Making New Vaccines

  2018cites this paper
• Latent Autoimmune Diabetes in Adults

  2018cites this paper
• Chronic insulin infusion induces reversible glucose intolerance in lean rats yet ameliorates glucose intolerance in obese rats.

  2017cites this paper
• Application of mesoscale simulation to explore the aggregate morphology of pH-sensitive nanoparticles used as the oral drug delivery carriers under different conditions.

  2017cites this paper
• Insulin and Immunotherapy in Children and Adolescents with Type 1 Diabetes

  2017cites this paper
• Intestinal type 1 regulatory T cells migrate to periphery to suppress diabetogenic T cells and prevent diabetes development

  2017cites this paper
• Current and future efforts toward the prevention of type 1 diabetes

  2016cites this paper
• The Effect of DPT-1 Intravenous Insulin Infusion and Daily Subcutaneous Insulin on Endogenous Insulin Secretion and Postprandial Glucose Tolerance

  2015cites this paper
• Novel diagnostic and therapeutic approaches for autoimmune diabetes--a prime time to treat insulitis as a disease.

  2015cites this paper
• Regulatory T Cells in Autoimmune Diabetes: Mechanisms of Action and Translational Potential.

  2015cites this paper
• Prevention and Reversal of Type 1 Diabetes—Past Challenges and Future Opportunities

  2015cites this paper
• Prevention and Reversal of Type 1 Diabetes d Past Challenges and Future Opportunities

  2015cites this paper
• Trials in the prevention of type 1 diabetes: current and future.

  2014cites this paper
• Prevention of Autoimmune Disease

  2014cites this paper
• Risk Factors and Primary Prevention Trials for Type 1 Diabetes

  2013cites this paper
• Non-antigenic and antigenic interventions in type 1 diabetes

  2013cites this paper
• Risk Factors and Primary Prevention Trials for Type 1

  2013cites this paper
• Immunotherapy Trials for Type 1 Diabetes: The Contribution of George Eisenbarth

  2013cites this paper
• Insulin and type 1 diabetes: immune connections.

  2013cites this paper
• Progress in immune‐based therapies for type 1 diabetes

  2013cites this paper
• Immune therapy in type 1 diabetes mellitus

  2013influential citation
• 60 – Technologies for making new vaccines

  2013cites this paper
• Strategies for the prevention of type I diabetes mellitus

  2013cites this paper
• Trials in type 1 diabetes: Antigen-specific therapies.

  2013cites this paper
• George S. Eisenbarth: Insulin and Type 1 Diabetes

  2013cites this paper
• DIABETIC STUDIES The Review of Chapter III . 4 Clinical Potential of Antigen-Specific Therapies in Type 1 Diabetes

  2013cites this paper
• Costs of Insulin-Dependent Diabetes Mellitus

  2012cites this paper
• Clinical potential of antigen-specific therapies in type 1 diabetes.

  2012cites this paper
• Pathophysiology of Immune-Mediated (Type 1) Diabetes Mellitus

  2012cites this paper
• Prevention Strategies for Type 1 Diabetes Mellitus

  2012cites this paper
• Prevention of Type I Diabetes Mellitus: The Role of Immune Interventions

  2011cites this paper
• What causes type 1 diabetes? Lessons from animal models

  2011cites this paper
• Immunotherapy of Type-1 Diabetes: Immunoprevention and Immunoreversal

  2011cites this paper
• Antigen-Based Immune Therapeutics for Type 1 Diabetes: Magic Bullets or Ordinary Blanks?

  2011cites this paper
• Inverse vaccination with islet autoantigens to halt progression of autoimmune diabetes

  2011influential citation
• Type 1 Diabetes: Clinical and Experimental

  2010cites this paper
• インターフェロン，リバビリン併用再治療前に抗GAD抗体強陽性を示し，早期インスリン投与にて1型糖尿病発症予防を試みたC型慢性肝炎の1例

  2010cites this paper
• Modified Vaccination Technique for Prophylactic and Therapeutic Applications to Combat Endogenous Antigen–Induced Disorders

  2010cites this paper
• Clinical and metabolic characteristics of patients with latent autoimmune diabetes in adults (LADA): absence of rapid beta-cell loss in patients with tight metabolic control.

  2010cites this paper
• Future drug treatment of Type 1 diabetes

  2010cites this paper
• Prediction, Prevention and Treatment of Virally Induced Type 1 Diabetes: A Dissertation

  2009cites this paper
• Signals required for the induction of antigen-based therapeutic tolerance

  2009cites this paper
• Advances in Type 1 diabetes therapeutics: immunomodulation and beta-cell salvage.

  2009cites this paper
• The Role of Immunomodulation Therapy in Autoimmune Diabetes

  2009cites this paper
• Insulin treatment in IA-2A-positive relatives of type 1 diabetic patients.

  2009cites this paper
• Mechanism of the year Curative and cell regenerative effects of 1-antitrypsin treatment in autoimmune diabetic NOD mice

  2009cites this paper
• Application of New Therapies in Graves' Disease and Thyroid-Associated Ophthalmopathy: Animal Models and Translation to Human Clinical Trials

  2008cites this paper
• Impact of diabetes susceptibility loci on progression from prediabetes to diabetes in at-risk individuals of the DPT 1 trial

  2008cites this paper
• Prevention of type 1 diabetes: the time has come

  2008cites this paper
• Vaccination against self to prevent autoimmune disease: the type 1 diabetes model

  2008cites this paper
• CHAPTER 10 – Diabetes Mellitus

  2008cites this paper
• Tiermodelle in der biomedizinischen Forschung

  2008cites this paper
• Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial.

  2008cites this paper
• Therapies aimed at preservation or restoration of beta cell function in type 1 diabetes.

  2008cites this paper
• Impact of Diabetes Susceptibility Loci on Progression From Pre-Diabetes to Diabetes in At-Risk Individuals of the Diabetes Prevention Trial–Type 1 (DPT-1)

  2008cites this paper
• Curative and β cell regenerative effects of α1-antitrypsin treatment in autoimmune diabetic NOD mice

  2008cites this paper
• New potential treatments for protection of pancreatic B-cell function in Type 1 diabetes

  2008cites this paper
• CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.

  2008cites this paper
• Prediction and Prevention of Type 1 Diabetes: Progress, Problems, and Prospects

  2007cites this paper
• Translational Mini‐Review Series on Type 1 Diabetes: Immune‐based therapeutic approaches for type 1 diabetes

  2007cites this paper
• Preventive Interventions for Type 1 Diabetes: History, Appraisal and Prospects

  2007cites this paper
• Immune intervention at diagnosis – should we treat children to preserve beta‐cell function?

  2007cites this paper
• The genetic basis of T and B cell contribution to autoimmune diabetes in NOD mice

  2006cites this paper
• HLA-Associated Cellular Diabetes with Antibodies Response to GAD to GAD in Type 2

  2006cites this paper
• CHAPTER 75 – Prevention of Autoimmune Disease: Type 1 Diabetes as a Paradigm

  2006cites this paper
• Treatment and prevention of obesity--are there critical periods for intervention?

  2006cites this paper
• NEW THERAPIES AIMED AT THE PRESERVATION OR RESTORATION OF BETA CELL FUNCTION IN TYPE 1 DIABETES

  2006cites this paper
• Downregulation of a pathogenic autoantibody response by IgM autoantibodies directed against the nephritogenic antigen in slowly progressive Heymann nephritis

  2006cites this paper
• Antigen-based prediction and prevention of type 1 diabetes.

  2006cites this paper
• Latent autoimmune diabetes in adults.

  2006cites this paper
• Insulin: a critical autoantigen and potential therapeutic agent in Type 1 diabetes

  2006cites this paper
• The Prospect of Vaccination to Prevent Type 1 Diabetes

  2005cites this paper
• Characterization of autoimmune response in preclinical type 1 diabetes

  2005cites this paper
• Immunology of type 1 diabetes.

  2005cites this paper
• Expression of human gltamic acid decarboxylase, a major autoantigen in Type 1 Diabetes, in transgenic plants

  2005cites this paper
• A look to the future: prediction, prevention, and cure including islet transplantation and stem cell therapy.

  2005cites this paper
• Handbook of preventive interventions for adults

  2005cites this paper
• Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease

  2005cites this paper
• Down‐regulation of pathogenic autoantibody response in a slowly progressive Heymann nephritis kidney disease model

  2004cites this paper
• Extrapancreatic insulin-producing cells in multiple organs in diabetes.

  2004cites this paper
• Differential immune response to B:9-23 insulin 1 and insulin 2 peptides in animal models of type 1 diabetes.

  2004cites this paper
• Type 1 Diabetes Mellitus: Epidemiology, Genetics, Pathogenesis And Clinical Manifestations

  2004cites this paper
• Charakterisierung von Insel-Autoantikörper-Subklassen im Verlauf des spontanen Autoimmunprozesses, bei Manifestation und nach Immunintervention bei Typ 1 Diabetes und im Tiermodell der NOD-Maus

  2004influential citation
• Prevention of type 1A diabetes: update.

  2004cites this paper
• Prediabetes: prediction and prevention trials.

  2004cites this paper
• Weight Gain, Improvements in Metabolic Profiles and Immunogenicity with Insulin or Sulphonylurea Administration in AIDS

  2004cites this paper
• TITLE: Epidemiologic Behavior of Diabetes Mellitus Type 1 in the Province of Camaguey 1993- 2002.

  2004cites this paper
• IX. Diabetes Prevention

  2004cites this paper
• High glucose potentiates cytokine- and streptozotocin-induced apoptosis of rat islet cells: effect on apoptosis-related genes.

  2004cites this paper
• The CORE Diabetes Model: Projecting Long-term Clinical Outcomes, Costs and Costeffectiveness of Interventions in Diabetes Mellitus (Types 1 and 2) to Support Clinical and Reimbursement Decision-making

  2004cites this paper
• HLA-DRB1 Alleles Contribute to Determining the Prognosis of Japanese Diabetes Mellitus Positive for Antibodies to Glutamate Decarboxylase

  2004cites this paper
• Preservation of C‐peptide secretion in subjects at high risk of developing type 1 diabetes mellitus – a new surrogate measure of non‐progression?

  2004cites this paper
• Autoimmune Central Diabetes Insipidus

  2004cites this paper